Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer

Background The subtype, density and location of tumor infiltrating T-cells are being explored as prognostic and predictive biomarkers in primary colorectal cancer (pCRC) and colorectal liver metastases (CLM). Very limited data exist comparing findings in pCRC and matched CLM. Patients and methods Fifty-eight patients with available pCRC and matched CLM (57/58 microsatellite stable) were included in this OSLO-COMET substudy. In immunohistochemically stained sections, total (Ttot), helper (TH), cytotoxic (CTL), and regulatory (Treg) T-cells were manually counted in hotspots from the invasive margin (IM), intratumor (IT), and tumor adjacent regions to determine T-cell densities. Results A striking accumulation of T-cells was found in IM of both pCRC and CLM with much lower densities in the IT region, exemplified by Ttot of 2838 versus 340 cells/mm2, respectively, in CLM. The correlation at the individual level between T-cell densities in pCRC and corresponding CLM was poor for all regions and T-cell subtypes; for instance, the correlation coefficient (R2) for IM Ttot was 0.07. The IT TH : CTL and Treg : TH ratios were 2.94 and 0.44, respectively, in pCRC, and 1.84 and 0.24, respectively, in CLM. Conclusion The observed accumulation of T-cells in the IM regions of pCRC and CLM with low penetration to the IT regions, combined with high TH : CTL and Treg : TH ratios, point to the presence of an immune suppressive microenvironment. T-cell densities of CLM differed markedly from the matched pCRC, indicating that to evaluate T-cell biomarkers in metastasis, the commonly available pCRC cannot serve as a surrogate for the metastatic tumor.

[1]  A. Cercek,et al.  Immunotherapy for the treatment of colorectal cancer , 2021, Journal of surgical oncology.

[2]  Yun Wang,et al.  Primary tumor immune score fails to predict the prognosis of colorectal cancer liver metastases after hepatectomy in Chinese populations , 2021, Annals of translational medicine.

[3]  S. Fox,et al.  Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer , 2020, Virchows Archiv.

[4]  F. Marincola,et al.  Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  B. Edwin,et al.  Neoadjuvant chemotherapy is associated with a transient increase of intratumoral T-cell density in microsatellite stable colorectal liver metastases , 2020, Cancer biology & therapy.

[6]  E. Dekker,et al.  Colorectal cancer , 2019, The Lancet.

[7]  E. Donnadieu,et al.  Obstacles to T cell migration in the tumor microenvironment. , 2019, Comparative immunology, microbiology and infectious diseases.

[8]  D. S. Bhullar,et al.  Biomarker concordance between primary colorectal cancer and its metastases , 2019, EBioMedicine.

[9]  H. Nishikawa,et al.  Regulatory T cells in cancer immunosuppression — implications for anticancer therapy , 2019, Nature Reviews Clinical Oncology.

[10]  J. Galon,et al.  Approaches to treat immune hot, altered and cold tumours with combination immunotherapies , 2019, Nature Reviews Drug Discovery.

[11]  A. Siriwardena,et al.  The OSLO-COMET Randomized Controlled Trial of Laparoscopic Versus Open Resection for Colorectal Liver Metastases. , 2018, Annals of Surgery.

[12]  A. Debucquoy,et al.  The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients. , 2018, Cancer cell.

[13]  P. Validire,et al.  The clinical role of the TME in solid cancer , 2018, British Journal of Cancer.

[14]  F. Marincola,et al.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.

[15]  K. Hirakawa,et al.  A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study , 2018, BMC Cancer.

[16]  J. Engstrand,et al.  Colorectal cancer liver metastases – a population-based study on incidence, management and survival , 2018, BMC Cancer.

[17]  F. Kühnel,et al.  CD4 and CD8 T lymphocyte interplay in controlling tumor growth , 2017, Cellular and Molecular Life Sciences.

[18]  J. Marsal,et al.  Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile , 2017, European Journal of Medical Research.

[19]  A. Børresen-Dale,et al.  Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases , 2017, Oncotarget.

[20]  H. Sakamoto,et al.  High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases. , 2017, Oncology reports.

[21]  H. Lee,et al.  Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer , 2016, Oncotarget.

[22]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[23]  Morten Wang Fagerland,et al.  Open versus laparoscopic liver resection of colorectal metastases: The Oslo-CoMet study , 2016 .

[24]  Z. Trajanoski,et al.  Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. , 2016, Immunity.

[25]  N. Halama,et al.  Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration , 2013, Oncoimmunology.

[26]  F. Marincola,et al.  The immune score as a new possible approach for the classification of cancer , 2012, Journal of Translational Medicine.

[27]  Axel Benner,et al.  Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. , 2011, Cancer research.

[28]  Gemma Navarro,et al.  Validation microsatellite path score in a population-based cohort of patients with colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Schreiber,et al.  Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.

[30]  D. Littman,et al.  Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. , 2011, Gastroenterology.

[31]  Zlatko Trajanoski,et al.  In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  M. Gonen,et al.  T Cell Infiltrate Predicts Long-Term Survival Following Resection of Colorectal Cancer Liver Metastases , 2009, Annals of Surgical Oncology.

[33]  Pornpimol Charoentong,et al.  Coordination of intratumoral immune reaction and human colorectal cancer recurrence. , 2009, Cancer research.

[34]  E. Aandahl,et al.  Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner , 2008, Cancer Immunology, Immunotherapy.

[35]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[36]  J. Hjelmborg,et al.  Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells , 2003, Cancer Immunology, Immunotherapy.

[37]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[38]  J. Machiels,et al.  Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival , 2018, Journal of the National Cancer Institute.

[39]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[40]  E. Abdalla,et al.  New paradigm in the management of liver-only metastases from colorectal cancer. , 2007, Gastrointestinal cancer research : GCR.

[41]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.